📰 Pharma Analyst News
Pharma Analyst News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharma Analyst. Real-time updates on events, politics, business and more.
June 8, 2024
Climate change-induced exacerbations will increase the number of multiple sclerosis cases.
May 25, 2024
24 May, 2024 Innovent Biologics mazdutide can pave way for transformative T2D treatment, says GlobalData Share Print page ...
May 18, 2024
GLP-1 drugs, the marvel drugs, in recent decades, have led the market significantly, with a market projection of $125 billion by 2033.
April 20, 2024
19 Apr, 2024 Roches PRX-002 shows promise in slowing Parkinsons disease motor progression, says GlobalData Share Print...
April 19, 2024
Data provesSemaglutideefficacy in treatment of Type 2 diabetes, obesity, heart failure, and chronic kidney failure, it emerges as important therapy in metabolic syndrome.
March 26, 2024
25 Mar, 2024 New wave of potential therapies to bring paradigm shift in COPD treatment, says GlobalData Share Print page ...
March 11, 2024
11 Mar, 2024 Early diagnosis continues to pose challenges for Parkinsons disease-modifying therapies, says GlobalData Share ...
February 22, 2024
Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies, says GlobalData
February 14, 2024
Otsuka Pharmaceutical is poised for a strategic transition as it approaches the loss of market exclusivity of Abilify Maintena (Aripiprazole) in Europe and the US in October 2024. This significant development signals a forthcoming shift in the drug’s sales trajectory, highlighting Otsuka’s readiness to embrace ...
January 18, 2024
The development of new weight loss medicines by pharma companies Novo Nordisk and Eli Lilly have been making great progress, but obesity care needs a much greater revolution, according to a report on Thursday.Novo Nordisk and Eli Lilly have ...